Rankings
▼
Calendar
RXRX FY 2019 Earnings — Recursion Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RXRX
Recursion Pharmaceuticals, Inc.
$2B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$44M
-2577.3% margin
Operating Income
-$62M
-3649.4% margin
Net Income
-$63M
-3654.3% margin
EPS (Diluted)
$-0.37
Cash Flow
Operating Cash Flow
-$57M
Free Cash Flow
-$61M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$101M
Total Liabilities
$226M
Stockholders' Equity
-$124M
Cash & Equivalents
$70M
← Q1 2020
All Quarters
